Virtus LifeSci Biotech Products ETF Rating $67.77 +0.06 (+0.09%) Closing price 08/28/2025 04:10 PM EasternExtended Trading$67.68 -0.08 (-0.13%) As of 08/28/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.87Holdings in BBP have an aggregate rating of Moderate Buy based on 318 analyst ratings issued in the past year covering 25 companies (53.7% of the portfolio).BBP Aggregate Price Target$67.77High Prediction$67.77Average Prediction$67.77Low Prediction$67.77Holdings in BBP have an aggregate price target of $67.77 and a range of $67.77 to $67.77 covering 25 companies (53.7% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.70%ARDXArdelyx$6.38+3.1%4.1262 of 5 stars3.00$11.50 80.3%10Insider Trade2.66%RYTMRhythm Pharmaceuticals$104.23+1.9%3.6592 of 5 stars3.07$101.57 -2.6%15Positive News2.53%ALNYAlnylam Pharmaceuticals$452.33-0.4%4.1711 of 5 stars2.85$405.33 -10.4%26Positive News2.42%AUPHAurinia Pharmaceuticals$12.08-0.2%2.9892 of 5 stars3.00$12.00 -0.7%3Positive News2.36%APLSApellis Pharmaceuticals$28.05-0.6%4.1397 of 5 stars2.58$34.12 21.6%19Positive News2.32%MIRMMirum Pharmaceuticals$75.53+1.2%3.3111 of 5 stars3.13$74.13 -1.9%8Positive News2.27%TARSTarsus Pharmaceuticals$58.16+0.6%1.8224 of 5 stars3.00$66.67 14.6%7Positive News2.26%LGNDLigand Pharmaceuticals$159.96+0.5%4.0873 of 5 stars3.00$165.17 3.3%6Positive NewsAnalyst Forecast2.25%MDGLMadrigal Pharmaceuticals$437.17+2.8%3.8891 of 5 stars2.90$459.25 5.1%10Positive NewsAnalyst Forecast2.25%INSMInsmed$134.97+0.3%3.797 of 5 stars2.94$132.57 -1.8%17Positive News2.16%HALOHalozyme Therapeutics$72.81-0.5%4.7061 of 5 stars2.18$67.11 -7.8%11Positive News2.12%TBPHTheravance Biopharma$13.97+1.2%2.1742 of 5 stars3.50$21.33 52.7%42.11%CRSPCRISPR Therapeutics$53.05-0.9%3.673 of 5 stars2.47$71.60 35.0%17Analyst Upgrade2.08%BBIOBridgeBio Pharma$52.57+6.0%4.2293 of 5 stars3.00$61.35 16.7%172.06%INCYIncyte$83.70-1.3%4.6696 of 5 stars2.33$81.60 -2.5%18Positive News2.03%FOLDAmicus Therapeutics$7.65+0.1%4.2997 of 5 stars2.80$16.22 112.1%10Positive News2.00%IONSIonis Pharmaceuticals$42.62-0.3%4.6263 of 5 stars2.86$59.64 39.9%14Options Volume1.99%KNSAKiniksa Pharmaceuticals International$33.50-0.6%2.4632 of 5 stars3.00$41.17 22.9%6Positive News1.96%TVTXTravere Therapeutics$17.70+1.5%2.3324 of 5 stars2.87$33.43 88.9%15Positive NewsAnalyst ForecastHigh Trading Volume1.89%REGNRegeneron Pharmaceuticals$579.61-1.3%4.8553 of 5 stars2.81$817.67 41.1%27Trending NewsAnalyst Forecast1.88%ACADACADIA Pharmaceuticals$26.23-1.3%4.0489 of 5 stars2.61$28.88 10.1%18Positive News1.87%ONCBeOne Medicines$297.96-0.7%1.4405 of 5 stars3.00$330.89 11.1%71.86%ASNDAscendis Pharma A/S$193.90+0.5%3.4078 of 5 stars3.00$243.36 25.5%15Positive News1.84%HRMYHarmony Biosciences$37.97-0.2%4.648 of 5 stars3.00$51.00 34.3%10Positive News1.82%AGIOAgios Pharmaceuticals$38.18-2.8%4.2836 of 5 stars2.75$56.33 47.5%8Positive News This page (NYSEARCA:BBP) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access